Radiofluorination using aluminum-fluoride (Al18F)

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-11

  McBride, William J ^a   Sharkey, Robert M ^a   Goldenberg, David M ^b  

^a IMMUNOMEDICS INC   (United States)

^b CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

Author keywords

Fluorine 18; Molecular imaging; Peptides; PET; Radiofluorination; Review

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4 DIACETIC ACID; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID 2 IMIDAZOLE DERIVATIVE; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID 2 NITROIMIDAZOLE ALUMINUM F 18; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID 2 NITROIMIDAZOLE DERIVATIVE; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID ARGINYLGLYCYLASPARTIC ACID ALUMINUM F 18; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID ARGINYLGLYCYLASPARTIC ACID GALLIUM GA 68; 1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID N ETHYLMALEIMIDE; ALUMINUM F 18 DERIVATIVE; ALUMINUM FLUORIDE; ARGINYLGLYCYLASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID F 18; FLUORINE 18; N ETHYLMALEIMIDE; NITROIMIDAZOLE DERIVATIVE; OCTREOTIDE[1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID] ALUMINUM F 18; OCTREOTIDE[1,4,7 TRIAZACYCLONONANE 1,4,7 TRIACETIC ACID] GA 68; PENTETIC ACID; PHENYLALANYLPROLYLPROLYLARGINYLGLYCYLASPARTIC ACID F 18; SOMATOSTATIN; UNCLASSIFIED DRUG;

CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; DRUG CLEARANCE; FLUORINATION; IMAGE ANALYSIS; IMAGE DISPLAY; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR IMAGING; NONHUMAN; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFLUORINATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 84878771516     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-36     Document Type: Review

References (54)

1. van Dalen J, Visser E, Laverman P, Vogel W, Oyen W, Corstens F, Boerman O: Effect of the positron range on the spatial resolution of a new generation pre-clinical PET-scanner using F-18, Ga-68, Zr-89 and I-124 [abstract]. J Nucl Med 2008, 49:s404P.
2. Fani M, Maecke HR, Okarvi SM: Radiolabeled peptides: valuable tools for the detection and treatment of cancer. Theranostics 2012, 2:481-501.
3. 18F for positron emission tomography. Curr Top Med Chem 2010, 10:1669-1679.
4. Ametamey SM, Honer M, Schubiger PA: Molecular imaging with PET. Chem Rev 2008, 108:501-1516.
5. 13N radiolabels for positron emission tomography. Angew Chem Int Ed Engl 2008, 47:8998-9033.
6. 18F-radiochemistry: synthesis and applications. Mini-Rev Org Chem 2007, 4:317-329.
7. Smith GE, Sladen HL, Biagini SC, Blower PJ: Inorganic approaches for radiolabelling biomolecules with fluorine-18 for imaging with positron emission tomography. Dalton Trans 2011, 40:6196-6205.
8. 18F] fluorine radiochemistry: basics, applications and challenges. Appl Sci 2012, 2:277-302.
9. 18F-aryltrifluoroborate conjugates for functional imaging. Am J Nucl Med Mol Imaging 2013, 3:44-56.
10. 19F exchange in BODIPY dyes: facile generation of positron emission tomography/fluorescence dual modality agents for tumor imaging. Theranostics 2013, 3:181-189.
11. 18F] fluoride. J Am Chem Soc 2012, 134:17456-17458.
12. Sharkey RM, Cardillo TM, Rossi EA, Chang C-H, Karacay H, McBride WJ, Hansen HJ, Horak ID, Goldenberg DM: Signal amplification in molecular imaging by pretargeting a multivalent, bispecific antibody. Nat Med 2005, 11:1250-1255.
13. -with a third ligand. Coord Chem Rev 1996, 141:23-32.
14. Li L: The biochemistry and physiology of metallic fluoride: action, mechanism, and implications. Crit Rev Oral Biol Med 2003, 14:100-114.
15. Antonny B, Chabre M: Characterization of the aluminum and beryllium fluoride species which activate transducin. Analysis of the binding and dissociation kinetics. J Biol Chem 1992, 267:6710-6718.
16. Scheinberg DA, Strand M, Gansow OA: Tumor imaging with radioactive metal chelates conjugated to monoclonal antibodies. Science 1982, 215:1511-1513.
17. Goldenberg DM, Chang CH, Rossi EA, McBride WJ, Sharkey RM: Pretargeted molecular imaging and radioimmunotherapy. Theranostics 2012, 2:523-540.
18. -. Biochem Biophys Res Commun 1988, 155:1194-1200.
19. Kimura E: Developments in functionalization of macrocyclic polyamines. Pure Appl Chem 1989, 61:823-828.
20. Andre JP, Macke H, Kaspar A, Kunnecke B, Zehnder M, Macko L: In vivo and in vitro (27)Al NMR studies of aluminum(III) chelates of triazacyclononane polycarboxylate ligands. J Inorg Biochem 2002, 88:1-6.
21. 18F radiolabeling for PET. J Nucl Med 2009, 50:991-998.
22. 18F-labeled hapten-peptide in mice with human tumor xenografts. Mol Cancer Ther 2010, 9:1019-1026.
23. 18F labeling of peptides with a fluoridealuminum chelate complex. Bioconjugate Chem 2010, 21:1331-1340.
24. Chong H-S, Garmestani K, Ma D, Milenic DE, Overstreet T, Brechbiel MW: Synthesis and biological evaluation of novel macrocyclic ligands with pendent donor groups as potential yttrium chelators for radioimmunotherapy with improved complex formation kinetics. J Med Chem 2002, 45:3458-3464.
25. 18F chelation. Bioconjugate Chem 2011, 22:1793-1803.
26. 18F-labeling study. Chem Commun 2011, 47:9732-9734.
27. McBride WJ, D'Souza CA, Karacay H, Sharkey RM, Goldenberg DM: New lyophilized kit for rapid radiofluorination of peptides. Bioconjugate Chem 2012, 23:538-547.
28. Kwekkeboom D, Krenning EP, de Jong M: Peptide receptor imaging and therapy. J Nucl Med 2000, 41:1704-1713.
29. 18F. J Nucl Med 2010, 51:454-461.
30. Laverman P, D'Souza CA, Eek A, McBride WJ, Sharkey RM, Oyen WJG, Goldenberg DM, Boerman OC: Optimized labeling of NOTA-conjugated octreotide with F-18. Tumor Biol 2012, 33:427-434.
31. 3-Octreotate analogs for PET. J Nucl Med 2011, 52:1441-1448.
32. 18F-labeled bombesin analog. J Nucl Med 2012, 53:947-952.
33. 2] targeting vector for positron emission tomography imaging of gastrinreleasing peptide receptor-expressing tissues. Proc Natl Acad Sci USA 2007, 104:12462-12467.
34. Xu G, Chance MR: Radiolytic modification of sulfur-containing amino acid residues in model peptides: fundamental studies for protein footprinting. Anal Chem 2005, 77:2437-2449.
35. 68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice. Bioconjugate Chem 2011, 22:2415-2422.
36. 18F-AlF-NOTA-RGD2 for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging 2011, 38:1732-1741.
37. 18F-AlF-NOTA-PRGD2. Eur J Nucl Med Mol Imaging 2012, 39:683-692.
38. Shetty D, Jeong DS, Kim YJ, Lee JY, Hoigebazar L, Lee Y-S, Lee DS, Chung JK: Development of a bifunctional chelating agent containing isothiocyanate residue for one step F-18 labeling of peptides and applications for RGD labeling. Bioorg Med Chem 2012, 20:5941-5947.
39. 18F-labeled dimeric RGD peptide. Contrast Media Mol Imaging 2013, 8:238-245.
40. 68Ga] Ga-NOTA-PRGD2 using a reference tissue model. PLoS One 2012, 7:e37506. doi:10.1371/journal. pone.0037506.
41. 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. J Nucl Med 2013, 54:691-698. doi:10.2967/jnumed.112.113563.
42. Hoigebazar L, Jeong JM, Lee JY, Shetty D, Yang BY, Lee YS, Lee DS, Chung JK, Lee MC: Syntheses of 2-nitroimidazole derivatives conjugated with 1,4,7-triazacyclononane-N, Ndiacetic acid labeled with F-18 using an aluminum complex method for hypoxia imaging. J Med Chem 2012, 55:3155-3162.
43. 18F]NOTA-DUPA-Pep. J Label Compd Radiopharm 2012, 55:320-325.
44. 18F]AlF-NOTA analog of exendin-4 for imaging of GLP-1 receptor in insulinoma. Theranostics 2012, 2:999-1009.
45. 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer. J Nucl Med 2012, 53:146-153.
46. 18F]AlF method. Appl Radiat Isot 2012, 70:200-204.
47. 18F-chelated prosthetic groups. J Nucl Med 2012, 53(Suppl 1):1536.
48. 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma. Eur J Nucl Med Mol Imaging 2012, 39:463-473.
49. HER2:342-affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography. Eur J Nucl Med Mol Imaging 2008, 35:1008-1018.
50. 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents. Bioconjugate Chem 2006, 17:1294-1313.
51. 18FLabeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors. J Nucl Med 2011, 52:270-278.
52. 111In-DTPA-ε-lysine as the primary metabolic and excretory product. Nucl Med Biol 1994, 8:1023-1024.
53. Behr TM, Goldenberg DM, Becker W: Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations. Eur J Nucl Med 1998, 25:201-212.
54. Tolmachev V, Altai M, Sandström M, Perols A, Karlström AK, Boschetti F, Orlova A: Evaluation of a maleimido derivative of NOTA for site-specific labeling of affibody molecules. Bioconjugate Chem 2011, 22:894-902.